These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18543344)

  • 1. Clarification on the detection of epoetin delta and epoetin omega using isoelectric focusing.
    Belalcazar V; Ventura R; Segura J; Pascual JA
    Am J Hematol; 2008 Sep; 83(9):754; author reply 754-5. PubMed ID: 18543344
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
    Dehnes Y; Hemmersbach P
    Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defending Dynepo detection.
    Gmeiner G; Reichel C; Kulovics R; Scheiblhofer V
    Drug Test Anal; 2010; 2(11-12):526-32. PubMed ID: 21204285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo).
    Llop E; Gutiérrez-Gallego R; Segura J; Mallorquí J; Pascual JA
    Anal Biochem; 2008 Dec; 383(2):243-54. PubMed ID: 18804089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
    Okano M; Sato M; Kaneko E; Kageyama S
    Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control.
    Lasne F; Martin L; Martin JA; de Ceaurriz J
    Haematologica; 2009 Jun; 94(6):888-90. PubMed ID: 19483162
    [No Abstract]   [Full Text] [Related]  

  • 8. A high-throughput test to detect C.E.R.A. doping in blood.
    Lamon S; Giraud S; Egli L; Smolander J; Jarsch M; Stubenrauch KG; Hellwig A; Saugy M; Robinson N
    J Pharm Biomed Anal; 2009 Dec; 50(5):954-8. PubMed ID: 19625154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoetin alpha, epoetin beta and darbepoetin alfa: two-dimensional gel electrophoresis isoforms characterization and mass spectrometry analysis.
    Caldini A; Moneti G; Fanelli A; Bruschettini A; Mercurio S; Pieraccini G; Cini E; Ognibene A; Luceri F; Messeri G
    Proteomics; 2003 Jun; 3(6):937-41. PubMed ID: 12833517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design.
    Reichel C
    Drug Test Anal; 2011; 3(11-12):883-91. PubMed ID: 22140023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatographic separation of recombinant human erythropoietin isoforms.
    Gokana A; Winchenne JJ; Ben-Ghanem A; Ahaded A; Cartron JP; Lambin P
    J Chromatogr A; 1997 Dec; 791(1-2):109-18. PubMed ID: 9463897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine.
    Belalcazar V; Gutiérrez Gallego R; Llop E; Segura J; Pascual JA
    Electrophoresis; 2006 Nov; 27(22):4387-95. PubMed ID: 17054082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". Problems associated with current anti-doping testing: is quality assessment a reliable solution?
    Salvagno GL; Guidi GC
    J Appl Physiol (1985); 2008 Dec; 105(6):1992-3; author reply 1997-8. PubMed ID: 19140255
    [No Abstract]   [Full Text] [Related]  

  • 14. New screening protocol for recombinant human erythropoietins based on differential elution after immunoaffinity purification.
    Mallorquí J; Gutiérrez-Gallego R; Segura J; de Bolòs C; Pascual JA
    J Pharm Biomed Anal; 2010 Jan; 51(1):255-9. PubMed ID: 19716252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of erythropoietin with chromatography and isoelectric focusing].
    Andreux JP; Frétault J; Piette M; Leclerc M
    Ann Pharm Fr; 1973 Jan; 31(1):29-36. PubMed ID: 4756098
    [No Abstract]   [Full Text] [Related]  

  • 16. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
    Desharnais P; Naud JF; Ayotte C
    Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IEF pattern classification-derived criteria for the identification of epoetin-delta in urine.
    Lamon S; Boccard J; Sottas PE; Glatz N; Wuerzner G; Robinson N; Saugy M
    Electrophoresis; 2010 Jun; 31(12):1918-24. PubMed ID: 20564689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GASepo-a software solution for quantitative analysis of digital images in Epo doping control.
    Bajla I; Holländer I; Minichmayr M; Gmeiner G; Reichel Ch
    Comput Methods Programs Biomed; 2005 Dec; 80(3):246-70. PubMed ID: 16260062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screen and confirmation of PEG-epoetin β in equine plasma.
    Chang Y; Maylin GM; Matsumoto G; Neades SM; Catlin DH
    Drug Test Anal; 2011 Jan; 3(1):68-73. PubMed ID: 21254454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.
    Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T
    Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.